BenchSci, a global leader in AI for preclinical research and drug discovery, announced a strategic partnership with Thermo Fisher Scientific, the world leader in scientific services and equipment. The collaboration aims to develop AI-powered research tools and digital solutions designed to accelerate experimental design and enhance R&D productivity for scientists worldwide.
The partnership will leverage BenchSci’s ASCEND™ AI technology to create new enterprise software solutions for scientific instruments, advanced web-based literature search tools, and optimized reagent selection. These innovations are intended to help researchers analyze large scientific datasets, design more effective experiments, and better utilize laboratory resources.
Liran Belenzon, CEO and co-founder of BenchSci, described their technology as an AI assistant that decodes scientific evidence through a proprietary biomedical knowledge graph and machine learning, expanding possibilities for researchers. Gianluca Pettiti, Executive Vice President at Thermo Fisher Scientific, highlighted that combining Thermo Fisher’s extensive product portfolio and global reach with BenchSci’s AI expertise will transform scientific modeling and speed up the path from research to medicine development.